Last update :
05/12/2025
References   References 3768  
Type : Manufacturer

Research teams :
Authors :
Title : Obinutuzumab (Gazyvaro®) - Summary of Product Characteristics
Reference : Roche Products Limited 2025

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
injectionObinutuzumab Anticancer drug
Stability in solutions Polyvinyl chloride Sodium chloride 0,9% 0,4 >> 20 mg/ml 2-8°C Not specified
72 Hour
Stability in solutions Polyvinyl chloride Sodium chloride 0,9% 0,4 >> 20 mg/ml <30°C Not specified
48 Hour
Stability in solutions Polyolefine Sodium chloride 0,9% 0,4 >> 20 mg/ml 2-8°C Not specified
72 Hour
Stability in solutions Polyolefine Sodium chloride 0,9% 0,4 >> 20 mg/ml <30°C Not specified
48 Hour
Compatible + Sodium chloride 0,9%
Incompatible + Glucose 5%

  Mentions Légales